HuagongsheHuagongshe Chemistry Print Report · For research reference only
(3-(Trifluoromethyl)-1,2,4-oxadiazol-5-YL)methanamine → 5-(4-chlorophenyl)-6-(2-hydroxyethoxy)-N-((3-(trifluoromethyl)-1,2,4-oxadiazol-5-yl)methyl)nicotinamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (3-(Trifluoromethyl)-1,2,4-oxadiazol-5-YL)methanamine | HCID 55263061 | — |
| Reactant | 5-(4-Chlorophenyl)-6-(2-hydroxyethoxy)nicotinic acid | HCID 66678621 | — |
| Product | 5-(4-chlorophenyl)-6-(2-hydroxyethoxy)-N-((3-(trifluoromethyl)-1,2,4-oxadiazol-5-yl)methyl)nicotinamide | HCID 56929565 | — |
Reaction Steps
The title compound was synthesized in analogy to Example 1 using 5-(4-chlorophenyl)-6-(2-hydroxyethoxy)nicotinic acid (example CI) and 3-trifluoromethyl-[1,2,4]oxadiazol-5-methanamine (example AK) as starting materials; LC-MS (UV peak area/ESI) 100.0%, 443.1 (M+H)+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08729105B2 |
| Source dataset | uspto-grants-2014_05 |
| ORD ID | ord-a521dfb97bf34c67aea3cd90f94bb6ba |
| Source note | uspto-grants-2014_05 |